Cooperation to tackle diseases in low- and middle-income countries
The Center for Veterinary Vaccine Innovation and Manufacturing (CVIM) and Purbright Institute signed a Memorandum of Understanding (MOU) with the University of Saskatchewan (USask) in late October. Vaccine Infectious Disease Organization (video). This MOU will enable expanded collaboration and training on vaccine production to advance innovation for animal health. According to a recent press release.
The partnership, signed in Pirbright on Thursday, October 26, will expand the global This will contribute to the health of animals.
C.V.I.M. The Purbright-based organization is supported by funding from the Bill & Melinda Gates Foundation, the Federal Development Agency and the Biotechnology and Biological Sciences Research Council (BBSRC). The organization was founded to address the unmet global need to develop vaccines to control diseases in livestock, including neglected zoonotic diseases that are a threat to public health. Support the development and deployment of vaccine technologies to combat livestock diseases and emerging livestock diseases.
The overall objective of CVIM is to bridge the gap between basic research and late-stage product development, and to support the development and production of vaccines primarily focused on orphan livestock and zoonotic diseases, including those affecting LMICs. to accelerate and to strengthen the UK’s vaccine development. Unique emergency response capabilities.
VIDO has nearly 50 years of expertise in vaccine development for emerging infectious diseases and is one of the world’s largest and most advanced containment level 3 agricultural (CL3-Ag) research facilities. VIDO’s new Vaccine Development Center (VDC) builds on his VIDO roots in veterinary medicine and expertise in developing animal models of disease. This is important because most new human infections originate from animals.
Both VDC and CVIM were established to accelerate commercial development and are recognized for their efforts to prioritize neglected livestock diseases and emerging zoonotic diseases.
“The growing collaboration between these two institutions is a testament to our partnership in addressing some of the major global challenges related to food security in the world, especially in low- and middle-income countries,” he said. Stated. Professor Brian Charleston Director of Perbright Research Institute, FRS.
“Our collaboration with CVIM is an important step in establishing a global network of leading groups capable of advancing discovery innovations towards commercialization,” said Dr. Volker Gerdts, VIDO Director and CEO. “This MoU strengthens VIDO’s commitment as Canada’s pandemic research center to address globally important infectious diseases and accelerate the commercialization of vaccines.”
“VIDO’s research efforts address diseases that can have serious effects on both humans and animals. These diseases pose risks to the health and well-being of all people,” said Peter from USask.・President Stoichev said. “VDC and CVIM are working together to combat this problem and create solutions that will benefit people around the world.”